Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by standudu
Group name EquipeCTCS
Item Type Journal Article
Title Machine Learning-Assisted Evaluation of Circulating DNA Quantitative Analysis for Cancer Screening
Creator Tanos et al.
Author Rita Tanos
Author Guillaume Tosato
Author Zahra Al Amir Dache
Author Laurence Pique Lasorsa
Author Geoffroy Tousch
Author Safia El Messaoudi
Author Romain Meddeb
Author Mona Diab Assaf
Author Marc Ychou
Author Denis Pezet
Author Johan Gagnière
Author Pierre-Emmanuel Colombo
Author William Jacot
Author Marie Dupuy
Author Antoine Adenis
Author Thibault Mazard
Author Caroline Mollevi
Author José María Sayagués
Author Jacques Colinge
Author Alain R. Thierry
Abstract While the utility of circulating cell-free DNA (cfDNA) in cancer screening and early detection have recently been investigated by testing genetic and epigenetic alterations, here, an original approach by examining cfDNA quantitative and structural features is developed. First, the potential of cfDNA quantitative and structural parameters is independently demonstrated in cell culture, murine, and human plasma models. Subsequently, these variables are evaluated in a large retrospective cohort of 289 healthy individuals and 983 patients with various cancer types; after age resampling, this evaluation is done independently and the variables are combined using a machine learning approach. Implementation of a decision tree prediction model for the detection and classification of healthy and cancer patients shows unprecedented performance for 0, I, and II colorectal cancer stages (specificity, 0.89 and sensitivity, 0.72). Consequently, the methodological proof of concept of using both quantitative and structural biomarkers, and classification with a machine learning method are highlighted, as an efficient strategy for cancer screening. It is foreseen that the classification rate may even be improved by the addition of such biomarkers to fragmentomics, methylation, or the detection of genetic alterations. The optimization of such a multianalyte strategy with this machine learning method is therefore warranted.
Publication Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
Volume 7
Issue 18
Pages 2000486
Date 2020-09
Journal Abbr Adv Sci (Weinh)
Language eng
DOI 10.1002/advs.202000486
ISSN 2198-3844
Library Catalog PubMed
Extra PMID: 32999827 PMCID: PMC7509651
Tags cancer, machine learning, original, screening
Date Added 2023/11/14 - 15:16:39
Date Modified 2023/11/14 - 15:47:17
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés